ACRS - Aclaris Therapeutics' (ACRS) CEO Neal Walker on Q2 2019 Results - Earnings Call Transcript
Aclaris Therapeutics, Inc. (ACRS)
Q2 2019 Earnings Conference Call
August 8, 2019 5:00 PM ET
Company Participants
Kamil Ali-Jackson – Chief Legal Officer
Neal Walker – President and Chief Executive Officer
David Gordon – Chief Medical Officer
Frank Ruffo – Chief Financial Officer
Jeff Wayne – Interim Head of Commercial
Conference Call Participants
Louise Chen – Cantor
Liav Abraham – Citi
Donald Ellis – JMP Securities
Tim Lugo – William Blair
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Q2 2019 Aclaris Therapeutics, Inc. Earnings Conference Call. At this time, all participants